Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Update

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 2,400 shares, a decrease of 92.6% from the December 15th total of 32,500 shares. Based on an average daily volume of 109,300 shares, the short-interest ratio is currently 0.0 days.

DSNKY traded down $0.20 during trading on Friday, reaching $23.24. 57,414 shares of the company were exchanged, compared to its average volume of 80,093. The company’s 50-day moving average is $25.07 and its two-hundred day moving average is $24.00. Daiichi Sankyo has a 12-month low of $18.05 and a 12-month high of $37.00.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Read More: Does a trade war provide a risk to the global economy?

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.